Jones said the increase in wages was «nowhere near the level of revenue growth» and this «reflects both the extent of [the Premier League's]
financial advantage over other leagues and the impact of domestic and European cost control measures».
In other words, the court wants to «level the playing field» so that one party can not impose
a financial advantage over the other.
This means, if one parent has a much greater
financial advantage over the other, this may play a role in determining custody.
Not exact matches
The lessons Fidelity (fnfv) is learning could give it a valuable
advantage at a time when
other big
financial institutions are dipping their toes into the world of cryptocurrencies, which are together worth well
over $ 100 billion today.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018
financial results; Gilead's ability to sustain growth in revenues for its antiviral and
other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or
other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see
advantages of these products
over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or
other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and
other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Some of our actual and potential competitors have
advantages over us, such as longer operating histories, significantly greater
financial, technical, marketing or
other resources, stronger brand and business user recognition, larger intellectual property portfolios and broader global distribution and presence.
Their primary sales
advantage over other financial products was higher advisor compensation, and these types of compensation differentials will be easy pickings for class - action suits.
Investment flows out of Japan have been an important factor shaping world
financial markets
over the past couple of years, not only because of overseas investment by Japanese residents, but also because non-residents have taken
advantage of cheap Japanese money to fund positions in
other markets.
President Trump claimed the deal was «less about the climate and more about
other countries obtaining a
financial advantage over the US».
According to
financial experts, college investors have a significant
advantage over other types of investors.
«This agreement is less about climate and more about
other countries getting a
financial advantage over the United States».
I have been trying to explain people about
advantage of having term plan
over traditional lic plans,
other financial planning g basics which you have mentioned in
other articles.
Being able to garner the loyalty of new users could give the company a significant
advantage over its competitors, as successful new traders will be likely to trade
other financial products offered by Ayondo.